The world is our lab

Medical dermatology is characterized by high unmet need and a rapid pace of innovation, which is unlocking new treatment options for patients. Scientific advances in the broader field of dermatology, inflammation and immunology are opening up new opportunities to leverage LEO Pharma’s decades of expertise in skin biology and clinical development.
Driven by our focus on raising the standard of care worldwide, our innovation model aims to leverage our deep in-house skin biology and dermatology expertise and tap into external innovation opportunities through partnerships to develop and expand access to transformative new treatments.

A key advantage of partnering with LEO Pharma is our regulatory expertise and robust commercial platform. Backed by decades of specialized dermatology experience, we not only excel in developing medicines for skin diseases, but also in successfully launching and delivering them to patients across the globe. Our strong regulatory expertise and commercial capabilities ensure access and sustained value for innovative therapies, making us the ideal partner at every stage from discovery to commercialization.


Our commitment extends globally and regionally, and we are continuously looking to join forces with partners who share our ambition to shape the future of medical dermatology.